Literature DB >> 10880299

Immunization against potential biological warfare agents.

T J Cieslak1, G W Christopher, M G Kortepeter, J R Rowe, J A Pavlin, R C Culpepper, E M Eitzen.   

Abstract

The intentional release of biological agents by belligerents or terrorists is a possibility that has recently attracted increased attention. Law enforcement agencies, military planners, public health officials, and clinicians are gaining an increasing awareness of this potential threat. From a military perspective, an important component of the protective pre-exposure armamentarium against this threat is immunization. In addition, certain vaccines are an accepted component of postexposure prophylaxis against potential bioterrorist threat agents. These vaccines might, therefore, be used to respond to a terrorist attack against civilians. We review the development of vaccines against 10 of the most credible biological threats.

Mesh:

Substances:

Year:  2000        PMID: 10880299     DOI: 10.1086/313812

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Pulmonary Manifestations of Bioterrorism.

Authors:  Renuka Heddurshetti; Wadchara Pumpradit; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

Review 2.  New vaccine development.

Authors:  Gregory A Poland; Dennis Murray; Ruben Bonilla-Guerrero
Journal:  BMJ       Date:  2002-06-01

3.  Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities.

Authors:  Tod J Merkel; Pin-Yu Perera; Vanessa K Kelly; Anita Verma; Zara N Llewellyn; Thomas A Waldmann; Joseph D Mosca; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 4.  Hospital planning for acts of terrorism and other public health emergencies involving children.

Authors:  S Chung; M Shannon
Journal:  Arch Dis Child       Date:  2005-12       Impact factor: 3.791

5.  Provider and health care system response to a bioterrorist attack.

Authors:  J D Malone
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-07

6.  Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.

Authors:  Dan-Yang Shi; Fu-Jia Liu; Yun-Yun Mao; Rong-Tian Cui; Jian-Sheng Lu; Yun-Zhou Yu; Xiao-Jie Dong; Zhi-Xin Yang; Zhi-Wei Sun; Xiao-Bin Pang
Journal:  Hum Vaccin Immunother       Date:  2019-07-26       Impact factor: 3.452

7.  Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity.

Authors:  Girish J Kotwal
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

8.  The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.

Authors:  A M Arenas-Gamboa; T A Ficht; M M Kahl-McDonagh; G Gomez; A C Rice-Ficht
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

9.  Subcutaneous administration of a recombinant vaccinia virus vaccine expressing multiple envelopes of HIV-1.

Authors:  K S Slobod; T D Lockey; N Howlett; R V Srinivas; S D Rencher; P J Freiden; P C Doherty; J L Hurwitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-20       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.